STX209 (Arbaclofen) for Autism Spectrum Disorders: An 8-Week Open-Label Study

Overview of attention for article published in Journal of Autism and Developmental Disorders, November 2013

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (76th percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 10,227 followers.

#STX209 (#Arbaclofen) for Autism Spectrum Disorders: An 8-Week Open-Label Study http://t.co/CDqZEsF22h #autism #baclofen #gabab #alltrials

Good: authors report a trial registration number! Bad: they report the wrong one http://t.co/3kziJ4D0xx autism arbaclofen open label study

Confirming that open-label trials of virtually anything give positive results in autism http://t.co/3kziJ4D0xx uncontrolled arbaclofen study